Infectious disease

AST-ISOT "Updates in BK Virus and CMV Treatment" Webinar

AST-ISOT "Updates in BK Virus and CMV Treatment" Webinar

The American Society of Transplantation (AST) and the Indian Society of Organ Transplantation (ISOT) present:

"Updates in BK Virus and CMV Treatment"
- Scheduled for Thursday, February 8th, 2024
...9:00 AM ET to 10:00 AM ET
...7:30 PM IST to 8:30 PM IST
- This is the second webinar in a series of GLobal Education Exchange (GLEE) sessions developed by AST and ISOT.

Speakers:
- BK Virus: Dr. Camille Kotton • Massachusetts General Hospital, Boston, MA
- CMV: Dr. Atul Humar • Ajmera Transplant Centre, UHN, Toronto, ON

Moderator:
- Dr. Dinesh Khullar • Max Super Speciality Hospital, Saket, New Delhi

Discussant:
- Dr. Pratik Das • RN Tagore Hospital, Mukundapur, Kolkata

Phage Therapy in Solid Organ Transplant Recipients – State of the Evidence and Future Directions

VIEW ON-DEMAND

After participating in this webinar, the attendee will be able to:

  1. Describe the current experience with bacteriophage therapy (history, safety, effectiveness)
  2. Describe challenges in treating SOT recipients with phages, including persons with LVADs and CF
  3. Understand the current research and clinical trial landscape to bring phages to the mainstream

Speakers:

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

Recorded live on Tuesday, November 16, 2021 • Hosted by AST's Community of Transplant Scientists (COTS)

"Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients"
(Sci Immunol. 2021 Jun 15;6(60):eabj1031. doi: 10.1126/sciimmunol.abj1031.)

Watch Video

T3 Webinar on Management of Multidrug Resistant Organisms...

T3 Webinar on Management of Multidrug Resistant Organisms...

"Management of Multidrug Resistant Organisms: Treatment and Prevention"
- Wednesday, October 27th, 2021, from 2:00 PM ET to 3:00 PM ET

Presenters:
- Jonathan Hand, MD, FIDSA, FAST • Medical Director, Transplant Infectious Diseases, Ochsner Health, New Orleans, LA
- Judith Anesi, MD, MSCE • Assistant Professor of Medicine and Epidemiology, University of Pennsylvania, Philadelphia, PA

Moderator:
- Stephanie Pouch, MD, MS, FAST • Associate Professor of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA

AST would like to thank the Infectious Disease Community of Practice (IDCOP) for recommending this topic to include as part of the T3 webinar series.

The Respiratory Microbiome After Lung Transplantation: Reflection or Driver of Respiratory Disease?

The Respiratory Microbiome After Lung Transplantation: Reflection or Driver of Respiratory Disease?

Recorded live on Tuesday, October 26, 2021 • Hosted jointly by AST's Infectious Disease Community of Practice (IDCOP) and Thoracic and Critical Care Community of Practice (TCC COP)

"The Respiratory Microbiome After Lung Transplantation: Reflection or Driver of Respiratory Disease?"
(Am J Transplant. 2021 Jul;21(7):2333-2340. doi: 10.1111/ajt.16568. Epub 2021 Apr 16.)

Watch Video

ASN/AST COVID-19 Kidney Transplant Roundtable: Life After Vaccination

ASN/AST COVID-19 Kidney Transplant Roundtable: Life After Vaccination

During this webinar, representatives from American Society of Nephrology (ASN), American Society of Transplantation (AST), Centers for Disease Control and Prevention (CDC), and the patient and general nephrology community will discuss what is currently known and unknown about COVID-19 vaccine efficacy in transplant recipients. The goal of this roundtable is to help clinicians prepare to counsel patients to navigate life after vaccination in the times ahead.  

Session Objectives: Upon completion of this session, this webinar will educate transplant nephrologists, nephrologists, and nephrology nurses in answering patient questions regarding the knowns and unknowns of COVID-19 vaccination efficacy.

The session will include:

  • Testimonial from transplant recipients
  • A review of the data describing COVID-19 vaccine response and efficacy in transplant recipients.
  • A review of the mounting unresolved issues, while we wait for additional data.
  • Roundtable panelists will answer questions from the audience.

AST/AJT Journal Club on PTLD (Hosted by IDCOP)

AST/AJT Journal Club on PTLD (Hosted by IDCOP)

Join us live on Tuesday, March 9, 2021, from 11:00 AM ET to 12:00 PM ET • Hosted by the AST Infectious Disease Community of Practice (IDCOP)

"Association of Antiviral Prophylaxis and Rituximab Use with Post-transplant Lymphoproliferative Disorders (PTLD): A Nationwide Cohort Study" (doi.org/10.1111/ajt.16423)

Speakers:
Laura Walti, MD; Inselspital, Bern University Hospital; Bern, Switzerland

Moderator:
Upton Allen; MBBS, MSc, FAAP; SickKids, University of Toronto; Toronto, Canada

AST/AJT Journal Clubs are free, but registration is required.

Pages

Subscribe to RSS - Infectious disease